OneChain Immunotherapeutics icon

OneChain Immunotherapeutics

report entityclaim entity
OneChain Immunotherapeutics, a spin-off from the Josep Carreras Leukemia Research Institute and ICREA, specializes in developing innovative CAR-T therapies for hematological cancers. Under the leadership of Dr. Pablo Menéndez, the company focuses on creating targeted treatments that specifically attack unique antigens in these diseases.
National Ranking
2012th
in Spain
Regional Ranking
23100th
in Western Europe
Global Ranking
93199th
worldwide
Rankings by SemRush